Key Points
- Insider sale: Maximus insider Michelle Link sold 3,208 shares for approximately $173,970, reducing her direct ownership by 18.77% to 13,881 shares.
- Stock and financial performance: Maximus shares opened at $52.72, near their one-year low of $51.04. The company recently exceeded quarterly EPS expectations but reported a 5.1% year-over-year revenue decline and issued fiscal 2026 EPS guidance of $7.90–$8.20.
- Investor outlook: Maximus pays a quarterly dividend of $0.33, yielding about 2.5%, while analyst sentiment has weakened to an average “Reduce” rating. Institutional investors own 97.21% of the company’s stock.
Maximus, Inc. (NYSE:MMS - Get Free Report) insider Michelle Link sold 3,208 shares of the company's stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $54.23, for a total value of $173,969.84. Following the transaction, the insider directly owned 13,881 shares in the company, valued at $752,766.63. This represents a 18.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Maximus Trading Down 1.5%
Maximus stock opened at $52.72 on Friday. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The stock has a market cap of $2.76 billion, a PE ratio of 7.79 and a beta of 0.59. The stock has a 50-day moving average of $57.31 and a two-hundred day moving average of $60.29. Maximus, Inc. has a one year low of $51.04 and a one year high of $100.00.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts' consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the previous year, the firm earned $2.16 earnings per share. The company's revenue was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, research analysts anticipate that Maximus, Inc. will post 8.03 EPS for the current fiscal year.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a $0.33 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a yield of 2.5%. Maximus's dividend payout ratio (DPR) is 19.50%.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on MMS shares. Weiss Ratings restated a "hold (c-)" rating on shares of Maximus in a research note on Monday, August 17th. Zacks Research downgraded shares of Maximus from a "hold" rating to a "strong sell" rating in a research note on Tuesday, August 11th. Finally, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Maximus has an average rating of "Reduce".
Read Our Latest Analysis on MMS
Institutional Trading of Maximus
A number of hedge funds and other institutional investors have recently made changes to their positions in MMS. BlackRock Inc. purchased a new position in shares of Maximus during the second quarter worth $400,186,000. Dimensional Fund Advisors LP boosted its holdings in Maximus by 7.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,107,278 shares of the health services provider's stock valued at $135,084,000 after purchasing an additional 141,362 shares during the last quarter. Reinhart Partners LLC. boosted its holdings in Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock valued at $106,575,000 after purchasing an additional 1,127,346 shares during the last quarter. Geode Capital Management LLC grew its position in Maximus by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider's stock worth $127,952,000 after purchasing an additional 5,130 shares during the period. Finally, Van Berkom & Associates Inc. grew its position in Maximus by 3.7% during the 1st quarter. Van Berkom & Associates Inc. now owns 1,172,190 shares of the health services provider's stock worth $75,137,000 after purchasing an additional 41,862 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.
About Maximus
(
Get Free Report)
Maximus, Inc (NYSE:MMS) is a provider of government services and technology-enabled solutions. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and support interactions between governments and the people they serve.
Its business activities include health and human services administration, employment and workforce services, child support and eligibility services, customer contact centers, program management, consulting and digital transformation.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
